title: Pediatric migraine.
abstract: Migraine headaches are common in children and adolescents, with a wide spectrum of clinical forms. The most frequent pattern in children is migraine without aura, characterized by attacks of frontal, pounding, nauseating headache lasting 1 to 72 hours. The spectrum of migraine with aura includes migraine with typical aura, hemiplegic migraine, and basilar-type migraine, all of which may manifest during early childhood and pose challenging diagnostic dilemmas. The periodic syndromes are a fascinating subset of migraine peculiar to extremely young children, which are viewed as "precursors" to more typical migraine and can be associated with frightening focal neurologic disturbances. Migraine treatment philosophy now embraces a balanced approach with biobehavioral interventions and acute and preventative pharmacologic measures. A growing body of controlled pediatric data is beginning to emerge regarding migraine treatment in children, lessening our dependence on extrapolated adult data.
authors.affiliation: Department of Pediatrics, Children's Hospital of The King's Daughters, Eastern Virginia Medical School, 601 Children's Lane, Norfolk, VA 23507, USA. dlewis@chkd.org
authors.forename: Donald W
authors.initials: DW
authors.lastname: Lewis
mesh_terms: D000293:Adolescent; D001521:Behavior Therapy / Q000379:methods; D002648:Child; D006801:Humans; D008881:Migraine Disorders / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology / Q000517:prevention & control / Q000628:therapy*; D020325:Migraine with Aura / Q000175:diagnosis / Q000628:therapy; D020326:Migraine without Aura / Q000175:diagnosis / Q000628:therapy; D011379:Prognosis; D017366:Serotonin Receptor Agonists / Q000627:therapeutic use*; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D017366:Serotonin Receptor Agonists